Following the UK government’s strategic AI response, the Department of Health and Social Care accepted formal recommendations to develop national best practices for managing agentic AI technologies throughout their lifecycle, from procurement to privacy impact assessments.
Building upon the findings, the government will “promote approaches that consider equity throughout the lifecycle of AI-enabled technologies, from development and evaluation through to deployment, monitoring and ongoing assurance”.
Whilst there is a 10-Year health plan for England, the Life Sciences Sector Plan, and a £10 billion technology investment commitment over three years, this will establish a blueprint for turning the UK into a globally leading, AI-enabled healthcare system, that actually audits manufacturers’ technology and defines the safe operational boundaries for AI model changes that are made in healthcare.
There will be consultations scheduled for Spring 2027 to update UK Medical Device Regulations.
The Medicines and Healthcare products Regulatory Agency will issue guidance to ensure AI developers use representative training data, preventing algorithms from worsening health disparities between vulnerable people.
Out of the 44 recommendations, healthcare agencies in England will ensure clear criteria underlying general-purpose AI models and dependencies, establish regulatory frameworks and assist healthcare organisations assessing readiness before adoption.
Also, they will expand initiatives like the AI Airlock programme and build regulatory sandboxes that accelerate safe innovation.
Public sector procurement is shifting from traditional software licensing to acquiring non-deterministic AI capabilities. The UK’s readiness assessment framework serves as a practical blueprint for government CIOs in Amsterdam tasked with modernizing IT infrastructure and managing vendor risk. Explore the Government Procurement & Digital Transformation sessions at Tech in Gov Europe.
